<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025388</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-SA-CRE-2009/1</org_study_id>
    <nct_id>NCT01025388</nct_id>
  </id_info>
  <brief_title>Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia</brief_title>
  <acronym>CEPHEUS</acronym>
  <official_title>Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ClinArt Company &amp; Signen Clinical Discoveries</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to establish the proportion of patients on lipid-lowering
      pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III/updated 2004
      NCEP ATP III guidelines, overall and by country, in the following sub-populations:

        -  Primary/secondary prevention patients.

        -  Patients with metabolic syndrome (according to NCEP III definition).

      In addition, the purpose is to establish the proportion of patients on lipid-lowering
      pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task
      Force guidelines/national guidelines, in the survey population and in the following
      sub-populations:

        -  Primary/secondary prevention patients.

        -  Patients with metabolic syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines, overall and by country.</measure>
    <time_frame>6 months- One visit only, no follow up visits.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients reaching the LDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III in the following sub-populations - Primary/secondary prevention patients - Patients with metabolic syndrome (according to NCEP III definition).</measure>
    <time_frame>6 months - One visit only, no follow up visits.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of patients reaching the LDL-C goals according to the Third Joint European Task Force guidelines / national guidelines, in the following sub-populations:-Primary/secondary prevention patients -Patients with metabolic syndrome.</measure>
    <time_frame>6 months- One visit only, no follow up visits.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">4053</enrollment>
  <condition>Hypercholesterolemia</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subject who visits the primary care clinics, cardiology clinics and internal medicine
        clinics, and who fulfil the inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  On lipid-lowering drug treatment for at least 3 months, with no dose change for a
             minimum of 6 weeks. Â·

          -  Subject must sign informed consent

        Exclusion Criteria:

          -  Subjects who are unwilling or unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Mohammed Arafah</last_name>
    <role>Study Chair</role>
    <affiliation>King Khalid University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Shorook Alherz</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Fahad National Guard Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Khalid Alnemer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Security Forces Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Hossam Alghetany</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soliman Fakieh Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Othman Metwally</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Fahad General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Akram Alkhadra</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Fahad University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Faisal Alanizi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health, Saudi Arabia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Riyadh</city>
        <state>Central</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dammam</city>
        <state>Eastern</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Aljouf</city>
        <state>North</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Jeddah</city>
        <state>Western</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Makah</city>
        <state>Western</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2009</study_first_submitted>
  <study_first_submitted_qc>December 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2009</study_first_posted>
  <last_update_submitted>February 7, 2013</last_update_submitted>
  <last_update_submitted_qc>February 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypercholesterolemia</keyword>
  <keyword>The study is focusing on the undertreatment of hypercholesterolemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

